Nautilus Biotechnology In... (NAUT)
0.87
0.04 (4.81%)
At close: Apr 02, 2025, 3:59 PM
0.88
0.99%
After-hours: Apr 02, 2025, 07:56 PM EDT
Nautilus Biotechnology Analyst Ratings
Total Analysts
3
Consensus Rating
Hold
Price Target
3
Upside
244.67
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Goldman Sachs | Sell | Downgrades | 3 2 | 101.06% | Dec 5, 2024 | |
| Guggenheim | Buy | Initiates | 6 | 589.34% | Jun 27, 2024 | |
| Jefferies | Hold | Assumes | 5 3 | 244.67% | Jun 3, 2024 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.